Friday, September 18, 2026

TOPICS

Home Tags Soliris

Tag: Soliris

ALEXION PHARMACEUTICALS reported a 17 percent decline in profit for the 2017 third quarter as the company's expenses rose on restructuring and its cost of sales. Above, the Alexion manufacturing facility in Smithfield, which the company remains committed to closing as part of its corporate restructuring. / COURTESY ALEXION

Alexion reports revenue up, profit down on restructuring costs

SMITHFIELD – New Haven, Conn.-based Alexion Pharmaceuticals Inc. reported a 17 percent year-over-year decline in net income for the 2017 third quarter to $78...
- Featured Event -

Latest News